Call for Abstract

Rescheduling of Progress in Radiology

The upcoming congress was postponed due to Covid-19 outbreak. The new schedule will be from September 29 to October 1 in 2021.

According to the new schedule, we would like to treat the abstracts submitted to PROGRESS IN RADIOLOGY 2021 (May) based on the following concept.
It would be great if you handle the submitted manuscript(s) through the Submission System Abstract submission is closed. Thank you for your submission.
New submissions to the Progress in Radiology 2021 (Sep-Oct) are welcome by the end of June.
Abstract submission closed on June 30, 2021. Thank you for your submission.

  • The abstracts submitted to Progress in Radiology 2021 (May) will be transferred to Progress in Radiology 2021 (Sep - Oct) without any request from the 1st author.
  • If you wish to withdraw your abstract(s), please cancel submission through the abstract submission page at your end.
  • If you wish to modify your abstract(s), you are able to revise it on the abstract submission page at your end.

For 2) and 3) please proceed from

If you have any inquiries, please do not hesitate to contact Congress secretariat.

PS: When a pandemic of COVID-19 pneumonia continues, we are thinking of holding a Web Conference as a substitute for usual meeting.

When having any inconvenience, please do not hesitate to contact us.

Fax: +81-11-633-6885 Phone: +81-11-688-9661

Submission Period

Abstract submission is closed. Thank you for your submission.
New submissions to the Progress in Radiology 2021 (Sep-Oct) are welcome by the end of June.
Abstract submission closed on June 30, 2021. Thank you for your submission.

Submission Requirements

Only abstracts that has NOT been previously published or presented can be submitted.
Abstract submissions can only be made electronically through the congress website during the submission period. (Abstracts submitted by e-mail, mail or fax CANNOT be accepted under any circumstance.)
Please submit your abstract by following the submission procedures.


The lead author must also be the presenter.
You may register up to 10 co-authors including the lead author.
You can also register up to 10 affiliations.

Conflict of Interest (COI) Disclosure

Conflict-of-Interest Policy requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict.
Please disclose any relationships or circumstances that might affect or appear to affect the research presented. These relationships include you or any individual with whom you directly share income.

The Program Committee requires that all presentations be as free of commercial bias as possible and that any information on commercial products or services be based on already generally accepted medical thinking. It is also preferred that generic drug names be used wherever possible and that any presentation referring to unlabeled or research-associated commercial products should disclose this situation to session attendees.

Title of Abstract

Please limit your abstract title to 40 words.

Body Text of Abstract

Please limit your body text of abstract to 300 words. (Spaces are not included.)
Do not include any figures, tables, charts, photographs or illustrations.

Submission Method

Abstract submission is accepted only through online registration. You can access the abstract submission website via Internet Explorer, Mozilla Firefox, Safari, Google Chrome only.

You can revise or delete your abstract any time before the deadline, but please note that any submission, revision, replacement of abstract nor withdrawal are NOT acceptable after the deadline.

Abstract Submission
Confirm / Modify / Delete Submitted Abstract

Submission Confirmation Notice

Once submission is completed, you will automatically receive an e-mail confirming the receipt of your abstract submission. This will be the only notice regarding abstract submission from our end. If you do not receive this e-mail within a day after submission, there is a possibility that your submission has not been processed successfully. If this is the case, please contact the Secretariat Office for JSRS2021 ( immediately for directions, before submission deadline.

Abstract Acceptance Notice

Please be informed the Congress President will be responsible for making the final decision regarding abstract acceptance, based on the reviewers’ assessments.

The submitting author will be notified at the e-mail address provided during submission, whether their abstract has been accepted, along with other details in Spring, 2021. It is the submitting author’s responsibility to ensure that e-mails from the Secretariat can reach them.

For Abstract Submission Inquiries, please contact:

Secretariat Office for JSRS2021
c/o Congrès Inc.
Sumitomo-Seimei Sapporo Bldg., 2-12, North 5, West 5,
Chuo-ku, Sapporo, 060-0005, Japan